JFL Life Sciences Limited Rights Issue Fails to Meet Subscription Requirements
JFL Life Sciences Limited announced today, March 24, 2026, that its rights issue did not achieve the minimum subscription requirement. The company had offered 3,29,95,323 equity shares with a face value of 10.00 per share at a price of 210.00 per share, in a ratio of one share for every one share held, as of March 10, 2026. The issue period ran from March 16, 2026, to March 24, 2026.The minimum subscription requirement, set at 90% of the issue size, was not met. Consequently, JFL Life Sciences will not proceed with the allotment of equity shares. The company will initiate a process to refund amounts held in ASBA accounts through KFin Technologies Limited, in coordination with relevant banks.
The Board of Directors meeting took place on March 24, 2026, commencing at 5:30 P.M. and concluding at 6:00 P.M. The announcement was made by JFL Life Sciences Managing Director, Iunml Ashwinkumar Patel.
Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.